Mechanism of Action: Reduction Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Reduction Activity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 204797-001 | Apr 15, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Exela Pharma | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 205643-001 | Nov 1, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Eugia Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 207358-001 | Feb 29, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 073664-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alvogen | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 203853-001 | Jun 21, 2012 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 074037-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Steriscience | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 217182-001 | Apr 19, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |